| Brand Name | Stelara |
| Generic Name | Ustekinumab |
| Drug Class | TNF-Alpha Inhibitor |
| Availability | Prescription |
| Manufacturer | Janssen Biotech (Johnson & Johnson) |
| Indications | Crohn's Disease, Ulcerative Colitis |
| Type | Subcutaneous Injection, IV Infusion |
| Doses | Induction: 130 mg, then Maintenance: 90 mg every 8 weeks |
| Route | SC Injection |
| Side Effects | Injection site reactions, infections, headache, fatigue |
| Interactions | Biologic agent; infection risk; avoid live vaccines |
| Overdose | Unknown; monitor and seek help. |
| Missed Dose | Take ASAP; consult provider for schedule. |
| Contraindications | Active infections, hypersensitivity |
| Alternatives | Adalimumab, Infliximab, Vedolizumab |
| Co-Pay Assistance Program | Available |
| Patient Assistance Program | Available |
Dr. Bharat Pothuri is a Board-Certified Gastroenterologist and Hepatologist. With extensive experience in digestive health, he specializes in advanced endoscopic procedures, chronic GI disorder management, and preventive care. Dr. Pothuri is dedicated to providing expert, patient-focused insights to help improve gut health and overall well-being.
Ustekinumab is used to treat autoimmune conditions like psoriasis, psoriatic arthritis, and Crohn�s disease by inhibiting interleukin-12 and interleukin-23, which play a role in the inflammatory process.
Ustekinumab works by blocking interleukin-12 and interleukin-23, cytokines involved in inflammation and immune response, thereby reducing symptoms of inflammatory diseases.
Common side effects include headache, fatigue, and upper respiratory infections. Serious side effects may include infections, allergic reactions, or blood disorders.
Ustekinumab is administered as an injection under the skin (subcutaneous) at scheduled intervals, with your healthcare provider determining the frequency.
Ustekinumab should be used during pregnancy only if the benefits outweigh the risks. Consult your healthcare provider before using it during pregnancy.
If you miss a dose, contact your healthcare provider to reschedule your injection. Do not attempt to make up for a missed dose on your own.
Yes, Ustekinumab may increase the risk of serious infections due to its immune-suppressing effects. It�s important to monitor for signs of infection during treatment.
Yes, Ustekinumab is also used to treat conditions such as psoriasis, psoriatic arthritis, and Crohn�s disease, depending on your healthcare provider�s recommendation.
It may take several weeks for Ustekinumab to show noticeable effects, particularly in conditions like psoriasis or Crohn�s disease.
Ustekinumab may interact with other immunosuppressive medications. Always inform your healthcare provider about all medications you're taking.
Related Conditions |
Related Blogs |
|---|---|
